| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $335.3M | $345.1M | $334.5M |
| YoY Revenue Growth % | -2.8% | +3.2% | — |
| Gross Profit | $105.8M | $103.9M | — |
| Gross Margin % | 31.5% | 30.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $15.8M | $9.7M | -$10.8M |
| Operating Margin % | 4.7% | 2.8% | -3.2% |
| Net Income (GAAP) | $8.6M | $5.9M | -$5.6M |
| EBITDA (Normalized) | $20.7M | $21.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$23.0M | $11.2M | -$174.2M |
| Capital Expenditures (CapEx) | $6.1M | $14.1M | — |
| Free Cash Flow (FCF) | -$29.1M | -$2.9M | -$174.2M |
| FCF Margin % | -8.7% | -0.8% | -52.1% |
| Return on Invested Capital (ROIC %) | 2.3% | 1.6% | — |
| Cash & Short-Term Equivalents | $4.4M | $4.7M | — |
| Total Debt (Short + Long Term) | $111.3M | $40.4M | — |
| Total Stockholders' Equity | $424.4M | $455.6M | — |